GlaxoSmithKline and XenoPort announce extension of GSK1838262 (XP13512) FDA review date to 9 February 2010
GSK and XNPT today announced that FDA has extended the original PDUFA goal date for its review of NDA for GSK to February 9, 2010.
Read the full article16y agoen
You might also wanna read
OpenAI No. 2 Executive Fidji Simo Steps Down from Full-Time Role to Focus on Health Recovery
Variety·4h ago
Why ambulance rides in the US are so expensive: The broken economics of emergency medical transport
davidoks.blog·6h agoModerna's mResvia gets shot in the arm from EU contract
pharmaphorum·6h ago
Australia news live: Hanson defends UK ‘fact-finding’ trip; Qantas tops airline punctuality table
The Guardian·6h ago
STAT+: FDA finalists under review
STAT·13h ago
STAT+: Prime wins Beam arbitration, clearing path to clinic
STAT·14h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.